Skip to main content
Article thumbnail
Location of Repository

Approaches to allergy detection using aptasensors

By Emile Brys, Sara Tombelli, Maria E. Minunni, Marco Mascini and Anthony P. F. Turner


1. Immunoglobulins and IgE Antibodies are glycoprotein molecules which are produced by plasma cells in response to an immunogen (1). They belong to a class of spherical proteins called globulins and are hence known as immunoglobulins (Igs). Their primary function is to mediate the host immune response by binding to antigens

Publisher: Taylor and Francis
Year: 2007
OAI identifier:
Provided by: Cranfield CERES

Suggested articles


  1. (2000). A blinded, multi-centre evaluation of two commercial in vitro tests for latex specific IgE antibodies. doi
  2. (1997). A national estimate of the economic costs of asthma.
  3. (1995). A new approach to determine the effect of mismatches on kinetic parameters in DNA hybridization using an optical biosensor. doi
  4. (1998). Adapting selected nucleic acid ligands (aptamers) to biosensors. doi
  5. (2000). Advances in surface plasmon resonance biosensor analysis. doi
  6. (1998). Affinity biosensing based on surface plasmon resonance detection. In: Rogers K and Mulchandani doi
  7. (1998). Affinity biosensors: techniques and protocols. doi
  8. (2002). An aptamer-based quartz crystal protein biosensor. doi
  9. (1996). An enzyme-linked oligonucleotide assay. doi
  10. (2000). Application of surface plasmon resonance towards studies of low-molecular-weight antigen-antibody binding interactions. doi
  11. (2003). Aptamers and SELEX: the technology. doi
  12. (1998). Aptamers as Ligands in Affinity Probe Capillary Electrophoresis. doi
  13. (1999). Aptamers: An emerging class of molecules that rival antibodies in diagnostics.
  14. (2002). Aptasensors – the future of biosensing? doi
  15. (1999). Asthma epidemiology: clues and puzzles. doi
  16. (2000). Asthma worldwide. doi
  17. (2001). Automated selection of anti-protein aptamers. doi
  18. (2003). Biosensors in clinical chemistry. doi
  19. (2002). Biosensors. Kirk-Othmer Encyclopaedia of Chemical Technology. doi
  20. (1997). Biotechnological applications of surface plasmon resonance. Trends in biotechnology 15: doi
  21. (2003). Clinical laboratory assessment of IgE-dependent hypersensitivity. doi
  22. (1992). Comparison of skin testing and three in vitro assays for specific IgE in the clinical evaluation of immediate hypersensitivity.
  23. (2001). Development of an immunosensor for the determination of allergy antibody (IgE) in blood samples Analytica Chimica Acta 442: 45 doi
  24. (2001). DNA electrochemical biosensors. doi
  25. (2004). Electric chips for rapid detection and quantification of nucleic acids. doi
  26. (2002). Electrochemical DNA biosensor for analysis of wastewater samples. doi
  27. (1979). Enzyme immunosensor. III. Amperometric determination of human chorionic gonadotropin by membrane-bound antibody.
  28. (2002). From IgE to Anti-IgE: Where do we stand? doi
  29. (1997). High affinity nucleic acid ligand containing modified nucleotides.
  30. (1998). HighAffinity RNA as a Recognition Element in a Biosensor. doi
  31. (1919). Horse asthma following blood transfusion: Report of a case. doi
  32. (1967). Identification of gamma-E-antibodies as a carrier of reaginic activity.
  33. (2003). IgE antibody in the serum – detection and diagnostic significance. doi
  34. (2001). Immobilized RNA switches for the analysis of complex chemical and biological mixtures.
  35. (1967). Immunological studies of an atypical (myeloma) immunoglobulin.
  36. (2000). Immunosensors in clinical analysis doi
  37. (2001). Immunosensors--principles and applications to clinical chemistry. Clinica Chimica Acta: doi
  38. (2000). Implementing surface plasmon resonance biosensors in drug discovery. doi
  39. (1990). In vitro selection of RNA molecules that bind specific ligands. doi
  40. (2000). In: Aptamers. Encyclopaedia of analytical chemistry. doi
  41. (1995). Increase of asthma, allergic rhinitis and eczema doi
  42. (1999). Integrated analytical sensors: the use of the TISPR-1 as a biosensor. doi
  43. (2002). Kinetic studies of RNA-protein interactions using surface plasmon resonance. doi
  44. Lundström I.1995. Biosensing with surface plasmon resonance — how it all started. Biosensors and Bioelectronics 10(8): i – ix. doi
  45. (2002). Molecular aspects of allergy. doi
  46. (1998). Molecular basis of allergic diseases. doi
  47. (2004). Molecular Imprinting, doi
  48. (2002). Monitoring post-translational modification of proteins with allosteric ribozymes. doi
  49. (2003). New trends in affinity sensing: Aptamers for ligand binding. doi
  50. (2003). Quartz crystal microbalance (QCM) affinity biosensor for genetically modified organisms (GMOs) detection. doi
  51. (1990). Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. doi
  52. (1999). Self-assembled monolayer-based piezoelectric crystal immunosensor for the quantification of total human immunoglobulin E. Analytical Biochemistry 273: 66 doi
  53. (2000). SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans. doi
  54. (1998). Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. doi
  55. (2000). Superantagonistic activation of ErbB-1 by EGF-related growth factors with enhanced association and dissociation rate constants.
  56. (1989). Surface plasmon microscopy. doi
  57. (1983). Surface plasmon resonance for gas detection and biosensing. doi
  58. (2000). Surface plasmon resonance imaging measurements of ultrathin organic films. doi
  59. (1999). Surface plasmon resonance sensors: review. doi
  60. (2000). Surface Plasmon Resonance-Based Immunoassays. doi
  61. (2001). Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition. doi
  62. (1996). Surface Plasmon Resonance. In: Commercial biosensors: applications to clinical, bioprocess, and environmental samples.
  63. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. doi
  64. (2004). The structure and function of immunoglobulins. doi
  65. (2001). The structure of the IgE Ce2 domain and its role in stabilizing the complex with its highaffinity receptor FceRI.
  66. (2001). The use of coated paramagnetic particles as a physical label in a magneto-immunoassay. Biosensors and Bioelectronics. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.